Get personalized, coordinated care across Northern California through the Sutter network.
View Patient Resources
Make appointments, message your doctor and more through our patient portal.
Enroll NowOur contributions to medical research and education lead to better healthcare outcomes.
Research at Sutter
Join our robust training programs led by nationally known healthcare leaders.
Explore OpportunitiesExplore the ways we provide innovative, compassionate care through our network.
Learn About Sutter Health
Shape the future of healthcare and build your career within our diverse teams.
Find Jobs13results found for:
Multiple sclerosis study to evaluate effectiveness and safety of fenebrutinib
Status: Active, Not Recruiting
Kaneka IED Coil System for the Treatment of Wide Necked Ruptured and Unruptured Intracranial Aneurysms (CLASS)
Status: Active, Recruiting
A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in A
Status: Active, Recruiting
An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Dimethyl Fumarate or Fingolimod to Ofatumumab
Status: Completed
Treatment of wide-neck intracranial aneurysms using the CITADEL Embolization Device
Status: Active, Recruiting
Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma (EMBOLISE)
Status: Active, Not Recruiting
An open-label, single-arm study to evaluate the effectiveness and safety of ocrelizumab in patients with early stage relapsing remitting multiple sclerosis.
Status: Completed
A PHASE III MULTICENTER, RANDOMIZED, DOUBLE BLIND, DOUBLE DUMMY, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB IN ADULTS WITH PROGRES
Status: Active, Not Recruiting
A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of Batoclimab Treatment in Adult Participants With Active Chronic Inflammatory D
Status: Active, Recruiting
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Rela
Status: Active, Recruiting
